Roche Holding

ROP · SIX · CHF

CHF 345.70−0.95%−CHF 3.30

Close · October 2, 2026

At a glance

Revenue growth: +1.54%; 2025 vs 2024
Net income growth: +55.61%; 2025 vs 2024
Net margin: 20.3%; 2024: 13.3%

Financial data

Amounts in millions of CHF; per-share values in CHF; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q4 2025	Q2 2025	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021
Total revenue	31,452	31,507	31,849	31,639	30,756	29,825	30,616	31,914	33,900	33,717
Cost of revenue	7,851	8,413	7,749	8,259	7,472	7,953	7,644	8,693	9,245	10,299
Gross profit	23,601	23,094	24,100	23,380	23,284	21,872	22,972	23,221	24,655	23,418
Selling, general and administrative	6,437	7,181	6,586	7,218	6,456	6,890	6,596	7,298	6,393	6,440
Research and development	5,976	6,309	6,226	6,932	6,440	6,941	6,604	7,189	6,410	7,175
Operating income	11,386	9,449	11,494	8,770	10,847	7,152	10,627	8,364	12,205	9,667
EBIT	11,386	9,449	11,494	8,770	10,847	7,152	10,627	8,364	12,205	9,667
EBITDA	12,956	10,993	13,036	10,378	12,339	8,702	12,216	10,141	13,931	11,656
Interest expense	564	579	608	623	625	423	405	350	258	174
Pre-tax income	8,973	7,385	9,588	3,570	8,223	4,905	9,174	5,342	10,985	7,511
Income tax	1,648	1,418	1,756	1,080	1,526	110	1,611	972	1,824	792
Net income	6,871	5,470	7,410	2,019	6,258	4,361	7,137	3,891	8,530	6,127
Net income to common shareholders	6,871	5,470	7,410	2,019	6,258	4,361	7,137	3,891	8,530	6,127
Basic EPS	8.63	6.87	9.31	2.53	7.85	5.46	8.93	4.87	10.65	7.24
Diluted EPS	8.52	6.81	9.23	2.51	7.80	5.44	8.87	4.82	10.54	7.14
Average shares (basic)	796	796	796	797	797	799	799	799	801	846
Average shares (diluted)	807	803	803	802	802	804	804	806	810	858